Summary:
Effective treatment options are mostly limited to hormone therapy, which despite being effective is associated with safety concerns such as increased risk of hormone-dependent cancers and cardiovascular adverse effects, including trombotic risk. Since hormone treatment is not an option for many women suffering from moderate and severe VMS, either because of contraindications or personal preferences, there is a strong medical need for an effective non-hormonal treatment option with improved benefit / risk balance.
Qualified Participants Must:
• Must be female
• Must be 40-65 years old
• Must have moderate to severe hot flashes
• Must be postmenopausal
Qualified Participants May Receive:
Free study related care (inclusing mammogram) in addition to compensation for time and travel